Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?
- Published In:
- Expert opinion on drug safety, 13(11), 1469-81 (2014)
- Authors:
- de Heer, Jocelyn, Göke, Burkhard
- Database ID:
- RPEP-02367
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02367APA
de Heer, Jocelyn; Göke, Burkhard. (2014). Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?. Expert opinion on drug safety, 13(11), 1469-81. https://doi.org/10.1517/14740338.2014.955013
MLA
de Heer, Jocelyn, et al. "Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?." Expert opinion on drug safety, 2014. https://doi.org/10.1517/14740338.2014.955013
RethinkPeptides
RethinkPeptides Research Database. "Are incretin mimetics and enhancers linked to pancreatitis a..." RPEP-02367. Retrieved from https://rethinkpeptides.com/research/de-2014-are-incretin-mimetics-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.